Magnetar Financial LLC
Q4 2023 13F-HR Holdings
Net value change ($000)
+20,319
(0.5%)
New positions
163
Sold out positions
239
Turnover %
63.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| HUM | 98,957 | 161.7% |
| PIONEER NATURAL RESOURCES CO | 79,587 | 2190.1% |
| WestRock Co | 63,711 | 263.6% |
| Karuna Therapeutics, Inc. | 63,327 | 9595.0% |
| SP Plus Corp | 52,532 | NEW |
| Olink Holding AB (publ) | 51,534 | NEW |
| Mirati Therapeutics, Inc. | 49,020 | NEW |
| ImmunoGen, Inc. | 48,308 | NEW |
| CI | 44,492 | 341.9% |
| NVS | 43,740 | 53.7% |
Top Reduces (Value $000, Stocks/ETFs)
| NEW RELIC, INC. | -98,319 | -100.0% |
| BAX | -91,399 | -100.0% |
| Abcam plc | -80,548 | -100.0% |
| AIY | -74,788 | -100.0% |
| Seagen Inc. | -74,084 | -100.0% |
| VMWA | -66,750 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -52,480 | -100.0% |
| MDT | -51,262 | -49.6% |
| NATIONAL INSTRUMENTS CORP | -50,423 | -100.0% |
| DENBURY INC | -46,509 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
10,716
(0.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|